Your browser doesn't support javascript.
loading
Clinical validation of genetic variants associated with in vitro chemotherapy-related lymphoblastoid cell toxicity.
Fasching, Peter A; Häberle, Lothar; Rack, Brigitte; Li, Liang; Hein, Alexander; Ekici, Arif B; Reis, Andre; Lux, Michael P; Cunningham, Julie M; Ruebner, Matthias; Jenkins, Gergory; Fridley, Brooke; Schneeweiss, Andreas; Tesch, Hans; Lichtenegger, Werner; Fehm, Tanja; Heinrich, Georg; Rezai, Mahdi; Beckmann, Matthias W; Janni, Wolfgang; Weinshilboum, Richard M; Wang, Liewei.
Affiliation
  • Fasching PA; Department of Gynecology and Obstetrics, Erlangen University Hospital, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
  • Häberle L; Department of Medicine, Division of Hematology/Oncology, University of California at Los Angeles, David Geffen School of Medicine, Los Angeles, CA, USA.
  • Rack B; Department of Gynecology and Obstetrics, Erlangen University Hospital, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
  • Li L; Department of Gynecology and Obstetrics, Biostatistics Unit, Erlangen University Hospital, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
  • Hein A; Department of Gynecology and Obstetrics, Ludwig-Maximilians-University Munich, Munich, Germany.
  • Ekici AB; Division of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Mayo Medical School-Mayo Foundation, Rochester, MN, USA.
  • Reis A; Department of Oncology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Lux MP; Department of Gynecology and Obstetrics, Erlangen University Hospital, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
  • Cunningham JM; Institute of Human Genetics, Erlangen University Hospital, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
  • Ruebner M; Institute of Human Genetics, Erlangen University Hospital, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
  • Jenkins G; Department of Gynecology and Obstetrics, Erlangen University Hospital, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
  • Fridley B; Department of Laboratory Medicine & Pathology, Mayo Clinic, Rochester, MN, USA.
  • Schneeweiss A; Department of Gynecology and Obstetrics, Erlangen University Hospital, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
  • Tesch H; Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.
  • Lichtenegger W; Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.
  • Fehm T; Department of Biostatistics, University of Kansas Medical Center, Kansas City, KS, USA.
  • Heinrich G; Division of Gynecologic Oncology, National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.
  • Rezai M; Department of Oncology, Onkologie Bethanien, Frankfurt, Germany.
  • Beckmann MW; Department of Gynecology and Obstetrics, Charité University Hospital, Campus Virchow, Berlin, Germany.
  • Janni W; Department of Gynecology and Obstetrics, Düsseldorf University Hospital, Heinrich Heine University, Düsseldorf, Germany.
  • Weinshilboum RM; Department of Gynecologic Oncology, Schwerpunktpraxis für Gynäkologische Onkologie, Fürstenwalde, Germany.
  • Wang L; Department of Breast Diseases, Breast Center of Düsseldorf, Luisenkrankenhaus, Düsseldorf, Germany.
Oncotarget ; 8(44): 78133-78143, 2017 Sep 29.
Article in En | MEDLINE | ID: mdl-29100455

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Language: En Journal: Oncotarget Year: 2017 Document type: Article Affiliation country: Alemania Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Language: En Journal: Oncotarget Year: 2017 Document type: Article Affiliation country: Alemania Country of publication: Estados Unidos